115 results found.
          
Conformis Up 2.3% in 2Q19 Amid Coverage Issues
Conformis posts 2Q19 revenue of USD $19.3MM, +2.3% vs 2Q18.
Conformis Establishes Alliance to Focus on ASC Joint Replacement
Conformis entered into an alliance with Regent Surgical Health to focus on outcomes in outpatient joint replacement in alternative...
Orthopedic Sales in Line with Seasonal Expectations for 1Q19
By Mike Evers The first quarter of 2019 brought modest growth to the orthopedic market, as expected seasonal softness and more competition in digital surgery platforms slowed sales for some of the largest players. The 25 companies listed herein had combined total orthopedic sales of $8....
ConforMIS Reports 1Q19 Revenue of $20.6MM, +5% vs. 1Q18
ConforMIS posts 1Q19 revenue of USD $20.6MM, +5% vs. 1Q18.
Revenue Review: 4Q18 and Full Year 2018 Performance Highlights for Public Companies
By Mike Evers Below you’ll find a summary of the major 4Q18 and full year 2018 developments for publicly-traded orthopedic companies. Exhibits 1 and 2 show 4Q18 and full year performance, respectively.  Companies continue to refine their strategies to improve sales mix ...
Robotics, ASCs Will Continue to Drive Knee Replacement Market Trends
By Mike Evers ORTHOWORLD estimates that the knee replacement market grew to just under $9 billion in 2018, a 3.1% increase vs. 2017, as shown in Exhibit 1. We expect this segment to remain a steady performer in the low single digits as price pressure erodes revenue from legacy products,...
AAOS Preview: First-Time Exhibitors, New Offerings on the Exhibit Floor
By Julie A. Vetalice The American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting is taking place March 12-16 in Las Vegas. The popular destination is expected to draw ~4,000 more attendees (total of ~30,000) and more exhibitors (~650) than last year’s meeting in New Orleans...
Knee Replacement Innovation Led by Materials, Design and Computer-Assisted Surgical Improvements
By Robert A Poggie, Ph.D., BioVera Inc.  
ConforMIS Reports 4Q18 Revenue of $22MM, +6.3% vs. 4Q17
ConforMIS posts 4Q18 revenue of USD $22MM, +6.3% vs 4Q17, with 2018 full ye...
Orthofix Acquires Distributor, Options Medical
Orthofix Medical acquired Options Medical, a former distributor of OFIX Bone Growth Therapies.
ConforMIS, Orthofix and OrthoPediatrics Report Preliminary 4Q18 and FY 2018 Results
Preliminary results for ConforMIS, Orthofix and OrthoPediatrics were mixed. While ConforMIS’ net revenue for the year grew in the double digits, adjusting for product-only revenue reveals a mostly flat year. Orthofix rode strong spinal implant sales to mid-...
Revenue Review: 3Q18 Performance Highlights and 2018 Projections for Public Companies, Continued
By Mike Evers In the exhibits below, we've added nine companies to round out our revenue review for 3Q18. As noted in last month's 
3Q18 and 9 Month 2018 Performance Highlights for Public Companies
By Mike Evers Our recap highlights 3Q18 developments and ORTHOWORLD's projection of 2018 full-year revenue for the first publicly traded orthopaedic companies to report. Exhibits 1 and 2 below show year over year company performance for 3Q18 and nine months ending September 30, 2018...
ConforMIS Reports 3Q18 Product Revenue of $18.3MM, +0.9% vs. 3Q17
ConforMIS posts 3Q18 product revenue of US $18.3MM, +0.9% vs 3Q17.
Joint Reconstruction Expected to Continue with Steady Growth
By Carolyn LaWell Joint reconstruction accounts for 37% of the global orthopaedic industry. We estimate that joint reconstruction product revenue surpassed $18 billion in 2017, an increase of $560.3 million or 3.2% vs. 2016. These numbers were published in
ConforMIS, Smith & Nephew Settle Patent Dispute
ConforMIS will receive US $10.5MM from Smith & Nephew to settle a 2016 patent infringement lawsuit.
Revenue Review: 1H18 Growth and 2Q18 Performance Highlights for Public Companies
by Julie A. Vetalice The 21 companies tracked below collectively grew +3.6% in 1H18 vs. 1H17, still on track to reach our estimates of +3.7% in orthopaedic industry growth for 2018 vs. 2017. Exhibits 1 and 2 reflect 1H18 results for public orthopaedic companies. The performan...
ConforMIS Posts 2Q18 Revenue
ConforMIS announced 2Q18 revenue of US $19.1MM, +3.3% vs. 2Q17, and 1H18 revenue of $38.8MM, -0.5% vs. 1H17.
Public Orthopaedic Companies: 1Q18 Revenue and Growth Drivers
By Julie A. Vetalice The 21 companies tracked in Exhibits 1 and 2 collectively grew +3.1% in 1Q18 vs. 1Q17, remaining on track alongside our estimates of +3.7% in orthopaedic industry growth for 2018 vs. 2017. (Review
ConforMIS Posts 1Q18 Revenue
ConforMIS announced 1Q18 revenue of US $19.7MM, -3.9% vs. 1Q17.
Public Orthopaedic Companies: 2017 Revenue and 2018 Sales Drivers
By Julie A. Vetalice The 20 companies tracked in Exhibits 1 and 2 collectively grew +3.0% in 2017 vs. 2016. Individually, you’ll notice some stellar performance in particular segments. (Our final estimates for 2017 orthopaedic industry revenue can be found in
New Total Knee and Hip Products Focus on Additive, Materials, Robotics
By Carolyn LaWell Orthopaedic device manufacturers’ ability to gain market share in the total knee and hip reconstruction spaces will be dependent upon their response to the shift of procedures to ambulatory surgery centers, an uptick in bundled payments and any or all measures fo...
ConforMIS iTotal CR Survivorship: 4-Year Data
Summarized registry data indicates that patients treated with the Conformis iTotal CR knee experienced a cumulative revision rate of 0.5%
ConforMIS Reports 4Q17, 2017 Revenue
ConforMIS posted 4Q17 revenue of US $20.8MM, -3.9% vs. 4Q16, and 2017 revenue of $78.1MM, -2.1% vs. 2016.
Recapping Your Predictions: Consolidations and Launches as Growth Opportunities
At the dawn of 2017, we published results of an ORTHOWORLD Membership survey in ORTHOKNOW. Among the questions, we asked you to predict: In 2017, where do the opportunities lie for you and your company? Your responses included new product launches; patient-specific implants and instrume...
  • ORTHOWORLD INC.
  • 8401 Chagrin Road, Suite 18
  • Chagrin Falls, Ohio 44023 USA
  • Phone: 440.543.2101 • Fax: 440.543.2122
  • ©1992-2019 ORTHOWORLD
  • All Rights Reserved.
  • Site Managed By:
  • Open Professional Group